546
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Outcomes of patients with up to 6 years of follow-up from a phase 2 study of idelalisib for relapsed indolent lymphomas

, , , , , , ORCID Icon, , , , & show all
Pages 1077-1087 | Received 31 Jul 2020, Accepted 16 Nov 2020, Published online: 10 Dec 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Andrea Ronchi, Antonello Sica, Paola Vitiello & Renato Franco. (2021) Dermatological Considerations in the Diagnosis and Treatment of Marginal Zone Lymphomas. Clinical, Cosmetic and Investigational Dermatology 14, pages 231-239.
Read now
Georgios Pongas & Bruce Cheson. (2021) Recent Advances in the Management of Patients with Relapsed/Refractory Follicular Lymphoma. Blood and Lymphatic Cancer: Targets and Therapy 11, pages 55-66.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.